IL-6: A regulator of the transition from neutrophil to monocyte recruitment during inflammation

Trends in Immunology

Volumn 24, Issue 1, 2003, Pages 25-29

  Kaplanski, Gilles ^a   Marin, Valérie ^a   Montero Julian, Félix ^b   Mantovani, Alberto ^c   Farnarier, Catherine ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b Immunotech   (France)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA1 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; CD31 ANTIGEN; CHEMOATTRACTANT; COMPLEMENT COMPONENT C5A; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LEUKOTRIENE B4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PHOSPHATIDYLSERINE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; BIOACCUMULATION; BIOLOGICAL MODEL; CELL ACTIVATION; CELL ACTIVITY; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE TRANSFORMATION; MONONUCLEAR CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; REVIEW; UPREGULATION;

EID: 0037213682     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)00013-3     Document Type: Article

References (40)

1. Ryan G.B., Majno G. Acute inflammation. Am. J. Pathol. 86:1977;185-274.
2. Melnicoff M.J., et al. Kinetics of changes in peritoneal-cell populations following acute inflammation. Cell. Immunol. 118:1989;178-191.
3. Doherty D.E., et al. Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils. Lab. Invest. 59:1988;200-213.
4. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
5. Bevilacqua M.P., Nelson R.M. Selectins. J. Clin. Invest. 91:1993;379-387.
6. Newman P.J. The biology of PECAM-1. J. Clin. Invest. 100:1997;S25-S29.
7. Utgaard J.O., et al. Rapid secretion of prestored interleukin-8 from Weibel-Palade bodies of microvascular endothelial cells. J. Exp. Med. 188:1998;1751-1756.
8. Sallusto F., et al. Distinct patterns and kinectics of chemokine production regulate dendritic-cell function. Eur. J. Immunol. 29:1999;1617-1625.
9. Yamashiro S., et al. MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-α plays a role in maximal MCP-1 mRNA expression. J. Leukoc. Biol. 65:1999;671-679.
10. Gimbrone M.A., et al. Interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science. 246:1989;1601-1603.
11. Romano M., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315-325.
12. Müllberg J., et al. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23:1993;473-480.
13. Desgeorges A., et al. Concentrations and origins of soluble interleukin-6 receptor-α in serum and synovial fluid. J. Rheumatol. 24:1997;1510-1516.
14. Taga T., et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.
15. Modur V., et al. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor α J. Clin. Invest. 100:1997;2752-2756.
16. Coletta I., et al. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Exp. Nephrol. 8:2000;37-43.
17. Sporri B., et al. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts. Int. Immunol. 11:1999;1053-1058.
18. Biswas P., et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 91:1998;258-265.
19. Hurst S.M., et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 14:2001;705-714.
20. Marin V., et al. The IL-6/soluble IL-6Rα autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin. J. Immunol. 167:2001;3435-3442.
21. Kaplanski G., et al. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-α-independent IL-8 secretion and E-selectin expression. J. Immunol. 158:1997;5435-5441.
22. Marin V., et al. Chemotactic agents induces IL-6Rα shedding from polymorphonuclear cells through involvement of a metalloproteinase of the TNF-α converting enzyme (TACE)-type. Eur. J. Immunol. 32:2002;2965-2970.
23. Xing Z., et al. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:1998;311-320.
24. Savill J.S., et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83:1989;865-875.
25. Kobayashi S.D., et al. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc. Natl Acad. Sci. USA. 99:2002;6901-6906.
26. Afford S.C., et al. The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J. Biol. Chem. 267:1992;21612-21616.
27. Whyte M.K.B., et al. Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 150:1993;5124-5134.
28. Savill J.S. Phagocytic docking without shocking. Nature. 392:1998;442-443.
29. Hart S.P., et al. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol. 159:1997;919-925.
30. Teder P., et al. Resolution of lung inflammation by CD44. Science. 296:2002;155-158.
31. Brown S., et al. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 418:2002;200-203.
32. Fadok V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101:1998;890-898.
33. McDonald P.P., et al. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells. J. Immunol. 163:1999;6164-6172.
34. Bellingan G.J., et al. In vivo fate of the inflammatory macrophage during the resolution of inflammation. Inflammatory macrophages do not die locally but emigrate to the draining lymph nodes. J. Immunol. 157:1996;2577-2585.
35. Randolph G.J., et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 282:1998;480-483.
36. Buckley C.D., et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22:2001;199-204.
37. Alonzi T., et al. Interleukin-6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:1998;461-468.
38. Yamamoto M., et al. IL-6 is required for the development of Th-1 cell-mediated murine colitis. J. Immunol. 164:2000;4878-4882.
39. Fenton R.R., et al. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 43:2002;737-743.
40. Atreya R., et al. Blockade of interleukin-6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6:2000;583-588.